7. Department of Pathology

centralnervoussystem.

JInfect

Chemother.

24(4):292-297. 2018.
1) Ueno K, Urai M, Izawa K, Otani Y, Yanagihara N,8) Watanabe T, Iwatsuki-Horimoto K, Kiso M, Nakajima

Kataoka M, Takatsuka S, Abe M, Hasegawa H, Shimizu

N, Takahashi K, Jose da Silva Lopes T, Ito M,K, Kitamura T, Kitaura J, Miyazaki Y, Kinjo Y. Mouse

Fukuyama S, Hasegawa H, Kawaoka Y. Experimental

LIMR3/CD300f

istheinfection of Cynomolgus Macaques

antimicrobialactivityRep.

pathogenic H5N1 influenza virus through the aerosol

anegativeofregulator

neutrophils.

ofSci8(1):17406. 2018.

with highlyroute. Sci Rep. 8(1):4801. 2018.

2) Tazaki T, Tabata K, Ainai A, Ohara Y, Kobayashi S,9) Kiso M, Lopes TJS, Yamayoshi S, Ito M, Yamashita M,

Ninomiya T, Orba Y, Mitomo H, Nakano T, Hasegawa

Nakajima N, Hasegawa H, Neumann G, Kawaoka Y.

H,K.

Combinationof

Polymerase Inhibitors in Nude Mice Infected WithIjiroK,Sawa

H,

Shape-dependent

SuzukiT,Niikuraadjuvanticity

nanoparticle-conjugated RNA adjuvants for intranasal
inactivatedinfluenzavaccines.

RSCAdv.

8:16527-16536. 2018.

Therapy

WithNeuraminidase

andInfluenza Virus. J Infect Dis. 217(6):887-896. 2018.
10) Iwatsuki-Horimoto

K,Nakajima

N,

IchikoY,Sakai-Tagawa Y, Noda T, Hasegawa H, Kawaoka Y.

3) Sano K, Ainai A, Suzuki T, Hasegawa H. Intranasal

Syrian Hamster as an Animal Model for the Study ofinactivated influenza vaccines for the prevention of

Human Influenza Virus Infection. J Virol. 92(4). pii:

seasonal influenza epidemics. Expert Rev Vaccines.

e01693-17. 2018.

17(8):687-696. 2018.

11) Yamazaki T, Nagashima M, Ninomiya D, Ainai A,

4) Terauchi Y, Sano K, Ainai A, Saito S, Taga Y,

Fujimoto A, Ichimonji I, Takagi H, Morita N, Murotani

Ogawa-Goto K, Tamura SI, Odagiri T, Tashiro M,K, Hasegawa H, Chiba J, Akashi-Takamura S.

Fujieda M, Suzuki T, Hasegawa H. IgA polymerization

Neutralizing

contributes to efficient virus neutralization on humanHydrodynamic Injection Have a Therapeutic Effect inupper respiratory mucosa after intranasal inactivatedLethal Influenza Infection. Front Immunol. 9:47. 2018.

influenzavaccineadministration.

HumVaccin

Immunother. 14(6):1351-1361. 2018.

Antibodies

InducedbyGene-Based

12) Hatta M, Zhong G, Gao Y, Nakajima N, Fan S, Chiba S,
Deering KM, Ito M, Imai M, Kiso M, Nakatsu S, Lopes

5) Hasegawa H, Sano K, Ainai A, Suzuki T. Application

TJ, Thompson AJ, McBride R, Suarez DL, Macken CA,of HTLV-1 tax transgenic mice for therapeutic

Sugita S, Neumann G, Hasegawa H, Paulson JC,intervention. Adv Biol Regul. 68:10-12. 2018.

Toohey-Kurth KL, Kawaoka Y. Characterization of a6) Catton M, Gray G, Griffin D, Hasegawa H, Kent SJ,Mackenzie J, McSweegan E, Mercer N, Wang L. 2017
international meeting of the Global Virus Network.
Antiviral Res. 153:60-69. 2018.

Feline Influenza A(H7N2) Virus. Emerg Infect Dis.
24(1):75-86. 2018.
13) Dan K, Takanashi K, Akiyoshi H, Munakata K,Hasegawa H, Ogawa K, Watanabe K. Mechanism of7) Kaneko M, Shikata H, Matsukage S, Maruta M,

Action of the Anti-Influenza Virus Active Kampo

Shinomiya H, Suzuki T, Hasegawa H, Shimojima M,(Traditional Japanese Herbal) Medicine, Hochuekkito.

Saijo

Pharmacology. 101(3-4):148-155. 2018.

M.

A

patient

thrombocytopenia

withsyndrome

lymphohistiocytosis-associatedsevereandfeverwith

hemophagocytic

involvementofthe14) Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I,
Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P,

Kashiwagi S, Wang J, Horiguchi M, Sato Y, Paudel S,

neutralizing antibody during cynomolgus monkey

Nanbo A, Miyazaki T, Hasegawa H, Maenaka K, Ohba

infection. J. Virol. 92:e00682-18. 2018.

Y. A Sialylated Voltage-Dependent Ca2+ Channel22) Fukushi S, Fukuma A, Kurosu T, Watanabe S,Binds Hemagglutinin and Mediates Influenza A Virus

Shimojima M, Shirato K, Iwata-Yoshikawa N, Nagata

Entry into Mammalian Cells. Cell Host Microbe.

N, Ohnishi K, Ato M, Melaku SK, Sentsui H, Saijo M.

23(6):809-818.e5. 2018.

Characterization of novel monoclonal antibodies against15) Takaki H, Kure S, Oshiumi H, Sakoda Y, Suzuki T,

theMERS-coronavirus

spike

proteinandtheir

Ainai A, Hasegawa H, Matsumoto M, Seya T. Toll-likeapplication in species-independent antibody detection

receptor 3 in nasal CD103+ dendritic cells is involved

by competitive ELISA. J Virol Methods. 251:22-29.

in immunoglobulin A production. Mucosal Immunol.

2018.

11(1):82-96. 2018.

23) Iwatsuki-Horimoto K, Nakajima N, Kiso M, Takahashi16) Takeda M, Watanabe S, Katano H, Noguchi K, Sato Y,K, Ito M, Inoue T, Horiuchi M, Okahara N, Sasaki E,Kojima S, Miura T, Majima R, Yamada S, Inoue N.

Hasegawa H, Kawaoka Y. The Marmoset as an Animal

Roles of GP33, a guinea pig cytomegalovirus-encoded

Model of Influenza: Infection With A(H1N1)pdm09 and

G protein-coupled receptor homolog, in cellular

Highlysignaling, viral growth and inflammation in vitro and inConventional or Tracheal Spray Route. Front Microbiol.

vivo. PLoS Pathog. 14:e1007487. 2018.

9:844. 2018.

PathogenicA(H5N1)

Virusesviathe17) Nanbo A, Katano H, Kataoka M, Hoshina S, Sekizuka T,24) Ngo DT, Phan PH, Kawachi S, Nakajima N, Hirata N,Kuroda M, Ohba Y. Infection of Epstein(-)Barr Virus inAinai A, Phung TTB, Tran DM, Le HT. Tuberculous

Type III Latency Modulates Biogenesis of Exosomes

pneumonia-induced severe ARDS complicated withand the Expression Profile of Exosomal miRNAs in theDIC in a female child: a case of successful treatment.

Burkitt Lymphoma Mutu Cell Lines. Cancers (Basel).

BMC Infect Dis. 18:294. 2018.

10:E237. 2018.
18) Murase Y, Maeda N, Katano H, Tsuzuki T. Fulminantadenovirus

hepatitis

withadenovirus-associatedesophagitis complicating malignant lymphoma. Pathol
Int. 68:259-261. 2018.
19) Katano

H.

PathologicalFeaturesofKaposi's

Sarcoma-Associated Herpesvirus Infection. Adv Exp
Med Biol. 1045:357-376. 2018.
20) Katano H. Expression and Function of Kaposi’sSarcoma-Associated Herpesvirus Non-coding RNAs.
Curr Clin Microbiol Rep. 5:211–218. 2018.
21) Fujii K, Sudaka Y, Takashino A, Kobayashi K, KataokaC, Suzuki T, Iwata-Yoshikawa N, Kotani O, Ami Y,
Shimizu H, Nagata N, Mizuta K, Matsuzaki Y, Koike S.
VP1 amino acid residue 145 of enterovirus 71 is a key
residue for its receptor attachment and resistance to